RxNorm Semantic Concepts Index - 272
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "272".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 272 | Charcoal activated | Designated preferred name (PT) | YES | |
RxCUI: 272 | Charcoal activated | Full form of descriptor (FN) | YES | |
RxCUI: 272 | Charcoal activated | Designated preferred name (PT) | YES | |
RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 272 | Charcoal activated | Full form of descriptor (FN) | YES | |
RxCUI: 27204 | Hydrogenase (NAD^+^) | Designated preferred name (PT) | NO | |
RxCUI: 27204 | Hydrogenase (NAD^+^) | Full form of descriptor (FN) | NO | |
RxCUI: 27204 | Hydrogenase (NAD^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27208 | hydroiodic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27220 | Hydroconchinine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27220 | Hydroconchinine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27220 | Hydroconchinine | Designated preferred name (PT) | NO | |
RxCUI: 27220 | Hydroconchinine | Full form of descriptor (FN) | NO | |
RxCUI: 27221 | hydrotalcite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 27221 | hydrotalcite | Designated preferred name (PT) | YES | |
RxCUI: 27221 | hydrotalcite | Full form of descriptor (FN) | YES | |
RxCUI: 27221 | hydrotalcite | Designated preferred name (PT) | YES | |
RxCUI: 27221 | hydrotalcite | Full form of descriptor (FN) | YES | |
RxCUI: 27224 | Hydroxyacylglutathione hydrolase | Designated preferred name (PT) | NO | |
RxCUI: 27224 | Hydroxyacylglutathione hydrolase | Full form of descriptor (FN) | NO | |
RxCUI: 27232 | Hydroxybutyrate-dimer hydrolase | Designated preferred name (PT) | NO | |
RxCUI: 27232 | Hydroxybutyrate-dimer hydrolase | Full form of descriptor (FN) | NO | |
RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Designated preferred name (PT) | NO | |
RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Full form of descriptor (FN) | NO | |
RxCUI: 27244 | Hyetellose-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27244 | Hyetellose-containing product | Designated preferred name (PT) | NO | |
RxCUI: 27244 | Hyetellose-containing product | Designated preferred name (PT) | NO | |
RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27244 | Hyetellose-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27244 | Hyetellose-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 27245 | Hydroxyethylflurazepam | Designated preferred name (PT) | NO | |
RxCUI: 27245 | Hydroxyethylflurazepam | Full form of descriptor (FN) | NO | |
RxCUI: 27249 | Hydroxyethylthiazole kinase | Designated preferred name (PT) | NO | |
RxCUI: 27249 | Hydroxyethylthiazole kinase | Full form of descriptor (FN) | NO | |
RxCUI: 27259 | Hydroxylamine oxidase | Designated preferred name (PT) | NO | |
RxCUI: 27259 | Hydroxylamine oxidase | Full form of descriptor (FN) | NO | |
RxCUI: 27260 | Hydroxylamine reductase | Designated preferred name (PT) | NO | |
RxCUI: 27260 | Hydroxylamine reductase | Full form of descriptor (FN) | NO | |
RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
RxCUI: 27267 | Hydroxylysine kinase | Designated preferred name (PT) | NO | |
RxCUI: 27267 | Hydroxylysine kinase | Full form of descriptor (FN) | NO | |
RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27274 | HMG-CoA reductase | Designated preferred name (PT) | NO | |
RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27274 | HMG-CoA reductase | Full form of descriptor (FN) | NO | |
RxCUI: 272758 | gallium (67Ga) citrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 272758 | gallium (67Ga) citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 27278 | Hydroxymethylpyrimidine kinase | Designated preferred name (PT) | NO | |
RxCUI: 27278 | Hydroxymethylpyrimidine kinase | Full form of descriptor (FN) | NO | |
RxCUI: 2728 | Collodion | Designated preferred name (PT) | NO | |
RxCUI: 2728 | Collodion | Full form of descriptor (FN) | NO | |
RxCUI: 272811 | Progest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 27288 | 4-hydroxyproline epimerase | Designated preferred name (PT) | NO | |
RxCUI: 27288 | 4-hydroxyproline epimerase | Full form of descriptor (FN) | NO | |
RxCUI: 27291 | hydroxypropyl cellulose | Designated preferred name (PT) | YES | |
RxCUI: 27291 | hydroxypropyl cellulose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27291 | hydroxypropyl cellulose | Full form of descriptor (FN) | YES | |
RxCUI: 27291 | hydroxypropyl cellulose | Designated preferred name (PT) | YES | |
RxCUI: 27291 | hydroxypropyl cellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 27291 | hydroxypropyl cellulose | Full form of descriptor (FN) | YES | |
RxCUI: 27296 | Hydroxypyruvate reductase | Designated preferred name (PT) | NO | |
RxCUI: 27296 | Hydroxypyruvate reductase | Full form of descriptor (FN) | NO |